Contrast-Enhanced Ultrasound (CEUS) in the Evaluation of Hemoperitoneum in Patients With Cirrhosis

J Ultrasound Med. 2023 Jan;42(1):247-253. doi: 10.1002/jum.16002. Epub 2022 May 17.

Abstract

Hemoperitoneum in cirrhosis is a life-threatening condition that requires emergent evaluation. Contrast-enhanced ultrasound (CEUS) permits multiple dynamic characterizations of abdominal structures through all vascular phases, and contrast extravasation or the presence of microbubbles in the ascites could be a sensitive tool. We reviewed 13 patients with cirrhosis that underwent CEUS due to high suspicion for intra-abdominal bleeding. In 10 cases, CEUS demonstrated extravasation of contrast, including 2 instances where CEUS detected active bleeding despite negative computed tomography. These data support further study of CEUS in direct comparison to other imaging modalities in this clinical context.

Keywords: CEUS; bleeding; cirrhosis; hemoperitoneum.

Publication types

  • Review
  • Case Reports

MeSH terms

  • Contrast Media*
  • Extravasation of Diagnostic and Therapeutic Materials
  • Hemoperitoneum*
  • Humans
  • Liver Cirrhosis
  • Ultrasonography

Substances

  • Contrast Media